DLH Holdings Corp. logo

DLH Holdings Corp.

DLHC

NASDAQIndustrialsSpecialty Business Services

Previous close

$4.53

$0.00 · 0.00%

Aug 21, 4:00 PM ET

DLHC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

70

Undervalued

Momentum

29

Weakening

Sentiment

64

Bullish

Risk resilience

50

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

DLH Holdings Corp., headquartered in Atlanta, Georgia, was established in 1969 and operated as TeamStaff, Inc. until its name change in June 2012. The company specializes in offering a range of technology-enabled business process outsourcing, comprehensive program management solutions, and public health research and analytics services throughout the United States, with a primary focus on the federal health services market. A significant portion of DLH's work involves defense and veterans' health, where it delivers integrated healthcare, technology, and logistical support. Key clients in this sector include the Department of Veterans Affairs (VA), the Defense Health Agency, the Tele-medicine and Advanced Technology Research Center, the Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. Additionally, the company provides diverse human services and solutions, covering areas such as rigorous monitoring and evaluation, efficient electronic medical records migration, robust data collection and management, and thorough nutritional and social health assessments. It also offers expert IT system architecture design, strategic migration planning, and continuous maintenance services. In the sphere of public health and life sciences, DLH undertakes crucial initiatives like clinical trials, epidemiological studies, and disease prevention. It actively promotes health among underserved and at-risk communities through the creation of impactful strategic communication campaigns, research into emerging health trends, in-depth health informatics analyses, and the application of proven best practices.

Industry
Specialty Business Services
Sector
Industrials
Headquarters
US
CEO
Kathryn Johnbull
Listed since
May 29, 1986
Employees
2,300

Market position

Day range

Current $4.53

52-week range

Current $4.53

Open
$4.57
Previous close
$4.53
Volume
4.7K
0.11× average
Average volume
41.91K
Average daily volume
Market cap
65.65M USD
Beta
1.46
Market reference 1
50-day average
$5.126
-11.63% below average
200-day average
$5.633
-19.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
226.13M USD
P/E (TTM)
-3.01×
P/B (TTM)
0.7×
P/S (TTM)
0.26×
EV / EBITDA
Earnings yield
1.68%
Free cash flow yield
28.26%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
16.26%
Operating margin
-0.11%
Net margin
-8.51%
Return on equity
1.21%
Return on assets
0.47%
Return on invested capital
5.03%

Financial health

Debt / equity
1.51×
Current ratio

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends23%15%7%-2%Gross margin, FY2021: 20.92%Gross margin, FY2022: 18.29%Gross margin, FY2023: 21.25%Gross margin, FY2024: 19.57%Gross margin, FY2025: 18.92%Operating margin, FY2021: 7.00%Operating margin, FY2022: 8.42%Operating margin, FY2023: 4.55%Operating margin, FY2024: 6.29%Operating margin, FY2025: 4.87%Net margin, FY2021: 4.12%Net margin, FY2022: 5.89%Net margin, FY2023: 0.39%Net margin, FY2024: 1.87%Net margin, FY2025: 0.40%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 20.92%. Gross margin FY2022 18.29%. Gross margin FY2023 21.25%. Gross margin FY2024 19.57%. Gross margin FY2025 18.92%. Operating margin FY2021 7.00%. Operating margin FY2022 8.42%. Operating margin FY2023 4.55%. Operating margin FY2024 6.29%. Operating margin FY2025 4.87%. Net margin FY2021 4.12%. Net margin FY2022 5.89%. Net margin FY2023 0.39%. Net margin FY2024 1.87%. Net margin FY2025 0.40%.

Income trends

Revenue

344.5M USD-12.99%

Operating income

16.79M USD-32.59%

Net income

1.36M USD-81.59%
Income trends across reported periods435.39M USD277.56M USD119.73M USD−38.1M USDRevenue, FY2021: 246.09M USDRevenue, FY2022: 395.17M USDRevenue, FY2023: 375.87M USDRevenue, FY2024: 395.94M USDRevenue, FY2025: 344.5M USDOperating income, FY2021: 17.22M USDOperating income, FY2022: 33.28M USDOperating income, FY2023: 17.09M USDOperating income, FY2024: 24.9M USDOperating income, FY2025: 16.79M USDNet income, FY2021: 10.15M USDNet income, FY2022: 23.29M USDNet income, FY2023: 1.46M USDNet income, FY2024: 7.4M USDNet income, FY2025: 1.36M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 246.09M USD. Revenue FY2022 395.17M USD. Revenue FY2023 375.87M USD. Revenue FY2024 395.94M USD. Revenue FY2025 344.5M USD. Operating income FY2021 17.22M USD. Operating income FY2022 33.28M USD. Operating income FY2023 17.09M USD. Operating income FY2024 24.9M USD. Operating income FY2025 16.79M USD. Net income FY2021 10.15M USD. Net income FY2022 23.29M USD. Net income FY2023 1.46M USD. Net income FY2024 7.4M USD. Net income FY2025 1.36M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue344.5M USD395.94M USD375.87M USD395.17M USD246.09M USD
Cost of goods sold279.33M USD318.45M USD296.02M USD322.89M USD194.61M USD
Gross profit65.16M USD77.49M USD79.86M USD72.29M USD51.48M USD
Selling, general, and administrative31.2M USD35.54M USD37.8M USD30.73M USD25.05M USD
Operating expenses48.38M USD52.59M USD62.77M USD39.01M USD34.26M USD
Interest income71K USD38K USD
Interest expense15.1M USD17.19M USD16.27M USD2.22M USD3.78M USD
Depreciation and amortization17.18M USD17.05M USD15.56M USD7.67M USD8.12M USD
Operating income16.79M USD24.9M USD17.09M USD33.28M USD17.22M USD
Net income1.36M USD7.4M USD1.46M USD23.29M USD10.15M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

3 ratings

Limited analyst sample: 3 ratings. Interpret the distribution with caution.

Strong buy00%
Buy3100%
Hold00%
Sell00%
Strong sell00%

Corporate actions

Corporate action history

Stock split

Effective Apr 21, 2008

1:4

Stock split

Effective Jun 2, 2000

2:7

DLHC peers

ETFs holding DLHC

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research DLHC

research.disclaimer